Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

31.540
-0.640-1.99%
Volume:9.96M
Turnover:314.16M
Market Cap:191.26B
PE:28.92
High:32.860
Open:32.380
Low:31.180
Close:32.180
52wk High:43.587
52wk Low:27.658
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:1.25
T/O Rate:0.16%
Dividend:0.50
Dividend Rate:1.57%
EPS(LYR):1.091
ROE:19.40%
ROA:9.08%
PB:4.32
PE(LYR):28.92
PS:10.26

Loading ...

Hong Kong Market Morning Digest: State Council Calls for Systematic Digital China Development; CITIC SEC Forecasts 69.59% H1 Net Profit Surge

Stock News
·
Jul 13

HANSOH PHARMA's Global Expansion Strategy: A Quiet but Steady Ascent

Deep News
·
Jul 12

Hansoh Pharmaceutical Says Hs-20,093 Meets Primary Endpoint in Phase III SCLC Trial

Reuters
·
Jul 10

Hansoh Pharma’s B7-H3 ADC HS-20093 Delivers Statistically Significant Overall-Survival Benefit in Phase III Small Cell Lung Cancer Trial

Bulletin Express
·
Jul 10

Hansoh Pharmaceutical - Hs-20,093 Meets Primary Endpoint in Phase Iii Sclc Trial

THOMSON REUTERS
·
Jul 10

GSK Flags Availability of Hansoh Pharma Update on Ris-rez Phase III China Trial Results

Reuters
·
Jul 10

Hansoh Pharma Says Hs-20093 Meets Overall Survival Endpoint in Phase 3 Small Cell Lung Cancer Trial

Reuters
·
Jul 10

Movement Alert|Hansoh Pharmaceutical Rises 3.08% in Regular Trading, Innovation Drug Payment Reform Catalyzes Sector-Wide Rally

Market Focus
·
Jul 10

Hansoh Pharmaceutical Group Stock Slips 3.0% in Hong Kong

Dow Jones
·
Jul 09

Movement Alert|Hansoh Pharmaceutical Falls 3.05% in Regular Trading, Trading at HK$31.2

Market Focus
·
Jul 09

Movement Alert|Hansoh Pharmaceutical Rises 3.07% in Regular Trading, Innovative Drug Pipeline Catalysts Continue Amid Sector Rebound

Market Focus
·
Jul 08

Hansoh Pharmaceutical Group Stock Sheds 4.2% in Hong Kong

Dow Jones
·
Jul 07

Movement Alert|Hansoh Pharmaceutical Falls 3.24% in Regular Trading, Pharmaceutical Sector Retreats After Prior Session Gains

Market Focus
·
Jul 07

Movement Alert|Hansoh Pharma Rises 3.74% in Regular Trading, HS-20136-2 Clinical Trial Approvals Continue to Drive Momentum Amid Pharma Sector Strength

Market Focus
·
Jul 06

Hansoh Pharmaceutical Group (SEHK:3692) Wins Trial Approval, Is It Fully Priced?

Simply Wall St.
·
Jul 05

Hansoh Pharma Keeps Share Base Steady at 6.06 Billion in June, Details HKD 4.68 Billion Convertible Bonds

Bulletin Express
·
Jul 03

Movement Alert|Hansoh Pharmaceutical Rises 4.41% in Regular Trading, HS-20136-2 Injection Receives Two Clinical Trial Approvals from NMPA

Market Focus
·
Jul 03

Hansoh Pharmaceutical Receives Dual NMPA Approvals for HS-20136-2 Injection Trials in Diabetes and Weight Management

Bulletin Express
·
Jul 02

Hansoh Pharma's HS-20136-2 Injection Receives NMPA Approval for Clinical Trials

Stock News
·
Jul 02

Hansoh Pharma Says China NMPA Clears Hs-20136-2 Injection for Clinical Trials in Type 2 Diabetes

Reuters
·
Jul 02